Loading...
•
Dec 31, 2024
Establishment Labs Q4 2024 Earnings Report
Establishment Labs reported its financial results for the fourth quarter and full year ended December 31, 2024, reaffirming its 2025 guidance.
Key Takeaways
Establishment Labs reported a fourth quarter revenue of $44.5 million, consistent with preannouncement, and a net loss from operations of $18.7 million, which was a 15% reduction compared to the prior year. The company also saw its adjusted EBITDA loss improve by 25% to $13.1 million.
Fourth quarter revenue reached $44.5 million, aligning with earlier preannouncements.
Motiva Implants were approved and launched in the U.S., contributing $3.3 million in U.S. revenue for the fourth quarter.
Net loss from operations decreased by 15% to $18.7 million compared to the same period last year.
Adjusted EBITDA loss improved by 25% to $13.1 million year-over-year.
Forward Guidance
Establishment Labs reaffirmed its 2025 revenue guidance of $205 million to $210 million, representing an increase of 23% to 26% over 2024, with U.S. revenue expected to be approximately $35 million.
Positive Outlook
- Reaffirmed 2025 revenue guidance of $205 million to $210 million.
- Anticipated 23% to 26% increase in 2025 revenue over 2024.
- Expected U.S. revenue of approximately $35 million in 2025.
- First quarter 2025 U.S. revenue expected to be approximately $5.5 million.
- Targeting first positive EBITDA quarter in 2025 and positive cash flow in 2026.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...